| Product Code: ETC12838645 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Latvia`s import shipments of influenza medications saw a steady growth rate of 7.03%, with a healthy compound annual growth rate (CAGR) of 8.6% from 2020 to 2024. The top exporting countries to Latvia included Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the presence of these key players, the market remained relatively competitive with low concentration, as indicated by the Herfindahl-Hirschman Index (HHI). This signifies a diverse and dynamic market landscape for influenza medication imports in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Influenza Medications Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Influenza Medications Market - Industry Life Cycle |
3.4 Latvia Influenza Medications Market - Porter's Five Forces |
3.5 Latvia Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Latvia Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Latvia Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Latvia Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Latvia |
4.2.2 Growing awareness about the importance of early treatment for influenza |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new influenza medications |
4.3.2 Competition from alternative treatments like home remedies and preventive measures |
5 Latvia Influenza Medications Market Trends |
6 Latvia Influenza Medications Market, By Types |
6.1 Latvia Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Latvia Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Latvia Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Latvia Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Latvia Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Latvia Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Latvia Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Latvia Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Latvia Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Latvia Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Latvia Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Latvia Influenza Medications Market Import-Export Trade Statistics |
7.1 Latvia Influenza Medications Market Export to Major Countries |
7.2 Latvia Influenza Medications Market Imports from Major Countries |
8 Latvia Influenza Medications Market Key Performance Indicators |
8.1 Average number of influenza cases reported annually in Latvia |
8.2 Adoption rate of new influenza medications in the market |
8.3 Percentage increase in healthcare spending on influenza treatment |
8.4 Patient adherence rates to prescribed influenza medications |
9 Latvia Influenza Medications Market - Opportunity Assessment |
9.1 Latvia Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Latvia Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Latvia Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Latvia Influenza Medications Market - Competitive Landscape |
10.1 Latvia Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Latvia Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here